Sensory Study: Taste and Tongue Biology (SweetTaste)

July 30, 2025 updated by: University of Massachusetts, Amherst

Researchers will investigate the correlation between a) self-reported dietary intake of foods and beverages, b) intensity of sucrose stimuli, and c) liking rating of sweet stimuli, with the relative expression of the taste receptor genes from human fungiform papillae (TAS1R2 and TAS1R3).

* This research will provide new information on how sweet taste perception is regulated.

  • The hypothesis: Greater dietary consumption of sugar and sweet foods is associated with reduced expression of the sweet taste receptors.
  • The results of this study could help to identify pathways to help modify sweet taste perception by uncovering this mechanism.

Participants will sample solutions prepared with sweet ingredients, provide salivary DNA, and collect fungiform papillae. This will allow researchers and investigators to compare the relationship between the sweetness of stimuli, genetic differences in sweet taste receptors, and expression levels of sweet taste receptor genes.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

121

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Amherst, Massachusetts, United States, 01003
        • University of Massachusetts

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Healthy adults, over the age of 18, able to provide consent in English, able to complete survey on an electronic device

Description

Inclusion Criteria:

  1. between 18 and 45 years old,
  2. have no tongue or cheek piercings,
  3. not a user of tobacco products or electronic cigarettes (within the last year),
  4. no known defects in taste or smell,
  5. not pregnant or breastfeeding,
  6. no history of chronic pain in the mouth,
  7. not taking any prescription pain medication,
  8. not taking any blood thinners,
  9. no history of cancer or cancer treatment,
  10. not diabetic or restricting intake of sugars for medical reasons, under the direction of a physician or healthcare provider
  11. willing to undergo the Fungiform Papillae biopsy procedure
  12. willing to provide salivary DNA
  13. Not currently experiencing any COVID-19 symptoms
  14. Not recently diagnosed (in the last 30 days) with COVID-19
  15. No history of high blood pressure

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gene expression and sweet taste perception
Time Frame: Day 1 (single time-point)
The relative level of gene expression of sweet taste receptors (TAS1R2 and TAS1R3) and relationship with sweet taste perception (gLMS ratings of sampled sucrose)
Day 1 (single time-point)
Gene expression and sweet taste liking
Time Frame: Day 1 (single time-point)
The relative level of gene expression of sweet taste receptors (TAS1R2 and TAS1R3) and relationship with sweet taste perception (hedonic ratings of sampled sucrose)
Day 1 (single time-point)
Gene expression and dietary intake
Time Frame: Day 1 (single time-point)
The relative gene level expression of sweet taste receptors and relationship with self-reported dietary intake of sweet foods and beverages
Day 1 (single time-point)
Gene expression and sweet liker status
Time Frame: Day 1 (single time-point)
The relative gene level expression of sweet taste receptors and relationship with the self-reported liking of a variety of sweet foods and beverages
Day 1 (single time-point)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Genetics and sweet taste perception
Time Frame: Day 1 (single time-point)
Genetic variability in sweet taste receptor genes and the relationship with perception of sweet stimuli (gLMS intensity ratings)
Day 1 (single time-point)
Genetics and sweet taste liking
Time Frame: Day 1 (single time-point)
Genetic variability in sweet taste receptor genes and the relationship with hedonic ratings of sweet stimuli (hedonic ratings)
Day 1 (single time-point)
Genetics and sweet liker status
Time Frame: Day 1 (single time-point)
Genetic variability in sweet taste receptor genes and the relationship with the self-reported liking of sweet-tasting foods and beverages
Day 1 (single time-point)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 20, 2023

Primary Completion (Actual)

April 20, 2025

Study Completion (Actual)

May 20, 2025

Study Registration Dates

First Submitted

July 13, 2023

First Submitted That Met QC Criteria

August 2, 2023

First Posted (Actual)

August 14, 2023

Study Record Updates

Last Update Posted (Actual)

August 5, 2025

Last Update Submitted That Met QC Criteria

July 30, 2025

Last Verified

May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2587
  • R21DC018906 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data will be shared at the request, after signing release form. No PHI will be included. All data will be de-identified. Data and meta-data will be shared, along with code books.

IPD Sharing Time Frame

Data will be available following publication of results.

IPD Sharing Access Criteria

Individuals can access the following signing form from IRB.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe